SOTIO Biotech a.s.
Clinical trials sponsored by SOTIO Biotech a.s., explained in plain language.
-
Can a smart drug hunt down sarcoma cells without harming healthy ones?
Disease control Not yet recruitingThis trial tests SOT106, a cancer medicine designed to find and kill cells that carry a marker called LRRC15, which appears on some osteosarcoma and soft tissue sarcoma tumors. The study has two parts: the first finds safe dose levels, and the second compares two doses to see whi…
Phase 1/2 • Sponsor: SOTIO Biotech a.s. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Smart missile drug takes aim at Hard-to-Treat colorectal cancer
Disease control Not yet recruitingThis trial tests a new medicine called SOT109 for people with advanced colorectal cancer that cannot be removed by surgery or has spread. SOT109 is designed to find and attack cancer cells that have a specific marker (CDH17) while sparing healthy cells. The study has two parts: t…
Phase 1/2 • Sponsor: SOTIO Biotech a.s. • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC